Q2 2024 Natera Inc Earnings Call Transcript
Good afternoon and welcome to Natera Inc.'s Q2 earnings conference call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the call over to Mike Brophy, Chief Financial Officer. Thank you. Please go ahead.
Thanks, operator. Thanks, operator, and good afternoon. Thank you for joining our conference call to discuss the results of our second quarter of 2024. On the line, I'm joined by Steve Chapman, our CEO; Solomon Moshkevich, President, Clinical Diagnostics; and Alex Aleshin, General Manager of Oncology and Chief Medical Officer.
Today's conference call is being broadcast live via webcast. We will be referring slide presentation that has been posted to investor.natera.com. A replay of the call will also be posted to our IR site as soon as it's available.
Starting on slide 2, during the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance, such as our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
